Presentations

  1. Determination of unbound piperaquine in human plasma.

  2. Unbound piperaquine exposure in children and pregnant women receiving dihydroartemisinin-piperaquine as malaria chemoprevention.

  3. Pharmacokinetics of piperaquine when used as malaria chemoprevention in HIV-infected children on antiretroviral therapy in Uganda.

  4. Video, 56 minutes: February CFAR Seminar: Ravindra Gupta with ESI Amelia Deitchman.

Oral presentations (2023–present)

  1. Deitchman AN. “Defining Drug Action for HIV Cure”. Bay Area Center for AIDS Research Seminar. February 7, 2024. UCSF ZSFG.

  2. Deitchman AN. “What will a cure to HIV look like?: an overview and advances in drug development efforts”. Pacific AIDS Education and Training Center (PAETC) HIV Learning Network (HIVLN). June 2023. Virtual Webinar.

Poster presentations (2020-present)

  1. Lance Kuo-Esser, Lance Calaguas, Kieu-My Huynh, Rachel Lee, Danielle Munoz, David Gingrich, Florence Marzan, Liusheng Huang, Catherine Godfrey, Daniel R. Kuritzkes, Michael M. Lederman, Priscilla Hsue, Steven G. Deeks, Timothy J. Henrich, Francesca T. Aweeka, Amelia N. Deitchman. Efavirenz and Dolutegravir May Alter Sirolimus Metabolism in People Living with HIV. American Society of Clinical Pharmacology and Therapeutics (ASCPT) 2024.

  2. Demi A. Sandel, Michael J. Peluso, Michiko Shimoda, Lily Zemelko, Alaa A. Latif, Amelia N. Deitchman, Gina Borgo, Nitasha A. Kumar, Meghann C. Williams, Barbara K. Felber, Gabriela Fragiadakis, Matthew H. Spitzer, Lillian Cohn, Steven G. Deeks, Rachel L. Rutishauser. Post-Intervention HIV Control Linked to Early In Vivo CD8+ T-Cell Proliferative Response to Rebound. Conference on Retroviruses and Opportunistic Infections, March 2024, Denver, CO.

  3. Amelia N. Deitchman, Leonid Serebryannyy, Rowena Johnston, Lucio Gama, Marina Caskey, Elena Vendrame, Devi SenGupta, Romas Geleziunas, Jackie Reeves, Christos Petropoulos, Michel Nussenzweig, Rachel Rutishauser, Steven G. Deeks, Michael J. Peluso. Effect of Broadly Neutralizing Antibody Exposure on HIV Rebound Following Combination Immunotherapy. Conference on Retroviruses and Opportunistic Infections, March 2024, Denver, CO.

  4. Peluso, M. J., Deitchman, A., Magombedze, G., Williams, M., Kumar, N., Mullins, J., Felber, B. K., Pavlakis, G., Johnston, R., Reeves, J., Gama, L., Nussenzweig, M. C., Henrich, T., Rutishauser, R. L., Deeks, S. G. (2023). Rebound Dynamics Following Immunotherapy with an HIV Vaccine, TLR9 Agonist, and bNAbs. Conference on Retroviruses and Opportunistic Infections, February 2023, Seattle, Washington.

  5. Usman Aslam-Mir, Howard Hong, Xay Pham, Richard Kajubi, Meghan Whalen, Norah Mwebaza, Erika Wallender, Grant Dorsey, Philip J Rosenthal, Francesca Aweeka, Liusheng Huang. Unbound piperaquine exposure in children and pregnant women receiving dihydroartemisinin-piperaquine as malaria chemoprevention, American Society of Tropical Medicine and Hygiene, October 2023, Chicago, Illinois.

  6. Liusheng Huang, Florence Marzan, David Gingrich, Beth Winger. Determination of deferasirox in K2EDTA-human plasma by LC-MS/MS, American Chemical Society, August 13-17, 2023, San Francisco, California.

  7. Tasissa H, Henrich T, Stock P, Deitchman A. Assessing the Relationship Between Cellular Tenofovir Concentrations and Anti-COVID-19 Activity in Kidney Transplant Patients with HIV. Vizient Pharmacy Conference 2022.

  8. Alba D, Schnittman S, Cheang RT, Beck-Engeser G, Chan F, Glidden D, Delaney J, Deitchman A, Aweeka F, Shigenaga JK, Grunfeld C, Crane H, Koliwad SK, Hunt PW. Inflammation and Kynurenine Pathway Linked to Type 2 Diabetes and Fat Fibrosis in HIV. Conference on Retroviruses and Opportunistic Infections 2022.

  9. Buck A, Drucker D, Peluso M, Deeks S, Rutishauser R, Henrich T, Deitchman A. Predicting COVID-19 Clinical Protective Immunity from SARS-CoV-2 T Cell Responses. Conference on Retroviruses and Opportunistic Infections 2022.

  10. Alba D, Schnittman S, Cheang RT, Beck-Engeser G, Chan F, Glidden D, Delaney J, Deitchman A, Aweeka F, Shigenaga JK, Grunfeld C, Crane H, Koliwad SK, Hunt PW. Distinct Cancers Have Distinct Inflammatory Predictors in Treated HIV. Conference on Retroviruses and Opportunistic Infections 2022.

  11. Andrews S, Henrich T, Aweeka F, Deitchman A. Sirolimus PK/PD and HIV-1 Reservoir Reduction. Vizient Pharmacy Conference 2021.

  12. Schnittman SR, Boeck J, Beck-Engeser G, Ahn H, Jone N, Deitchman AN, York V, Hartig H, Hoh R, Becht FM, Martin JN, Aweeka F, Deeks SG, Milush J, Hunt PW. Early Art Initiation May Preserve Influenza Vaccine Response Durability. Conference on Retroviruses and Opportunistic Infections (CROI) 2021. Virtual.

  13. Schnittman SR, Deitchman AN, Beck-Engeser G, Ahn H, York VA, Hartig H, Hoh R, Hecht FM, Martin JN, Deeks SG, Aweeka F, Hunt PW. Kynurenine Pathway Activity Remains Abnormal Despite Very Early ART Initiation. Conference on Retroviruses and Opportunistic Infections (CROI) 2020.